MariMed Inc. provides consulting services for the design, development, operation, management, and optimization of medical cannabis cultivation, production, and dispensary facilities.
The last earnings update was 6 days ago.
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
MariMed. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
MariMed's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MariMed has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Professional Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare MariMed's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare MariMed's earnings growth to the United States of America market average as no estimate data is available.
Unable to compare MariMed's revenue growth to the United States of America market average as no estimate data is available.
Unable to determine if MariMed is high growth as no earnings estimate data is available.
Unable to determine if MariMed is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access MariMed's filings and announcements here.
MariMed's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Robert N. Fireman, also known as Bob, has been Chief Executive Officer and President of MariMed Inc. since July 2017. Mr. Fireman is a Co-Founder of Me4Sure Inc and serves as its Chief Executive Officer. Mr. Fireman served as Chief Executive Officer at MariMed Advisors, Inc. His experience includes direct marketing and loyalty programs, identity security, hydroponic farming, medical billing and many other consumer facing applications. Mr. Fireman founded SmartSource Direct Inc., a subsidiary of News America Marketing (News Corp) and served as its General Manager. As an entrepreneur, he was the Founder of Consumer Card Marketing (CCMI)and serves as its Chief Executive Officer. Mr. Fireman was responsible for the development, marketing and distribution of card-based loyalty, financial and database products & services in retail, grocery and drug store chains encompassing over 50,000 stores throughout the U.S. He has been a practicing attorney for over 25 years and is the managing attorney of Fireman & Associates LLP. He has been active in the development, funding and operations of Medical Marijuana facilities over the last several years. His legal acumen, entrepreneurial experience and understanding of commercial agriculture are a tremendous asset to Fireman & Associates. Mr. Fireman joined the Worlds team as a seasoned executive in the building of technology and consumer driven companies. He has been a Director of Worlds Inc, since September 11, 2007 and Worlds Online Inc. since January 25, 2011. He serves as a Director of MariMed Inc. He serves as a Director of Me4Sure Inc. Mr. Fireman holds a BA degree from the University of Wisconsin and a JD from Suffolk University Law School.
Insufficient data for Bob to compare compensation growth.
Bob's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the
management team in years:
The tenure for the MariMed management team is about average.
Chief Operating Officer
Chief Information Officer
Vice President of Marketing
Vice President of Product & Sales
Chief Strategy Officer
Chief Innovation Officer
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The average tenure for the MariMed board of directors is less than 3 years, this suggests a new board.
Board of Directors
Who owns this company?
Recent Insider Trading
No 3 month open market individual insider trading information.
MariMed Inc. provides consulting services for the design, development, operation, management, and optimization of medical cannabis cultivation, production, and dispensary facilities. It also develops and manages facilities for the cultivation, production, and dispensing of medicinal and recreational cannabis, and cannabis-infused products under the Kalm Fusion, Betty’s Eddies, and Nature’s Heritage brand name. In addition, the company offers regulatory, accounting, human resources, and administrative services. It had secured 13 cannabis licenses for clients in Delaware, Illinois, Nevada, Rhode Island, Massachusetts, and Maryland. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.